Program Schedule

Vaccines: Meningococcal

Friday, October 10, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

Tracks: Pediatric ID, Adult ID

Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination
Stanley L. Block, MD ; Shane Christensen, MD ; Bikash Verma, MD ; Fang Xie, PhD ; Pavitra Keshavan, MD ; Peter M Dull, MD ; Igor Smolenov, MD
  • 1080_Block_et_al_IDWPoster.pdf (254.9 kB)
  • Immunogenicity of Human Papilloma Vaccine Coadministered with an Investigational Bivalent rLP2086 Vaccine Against Meningococcal Serogroup B in Healthy Adolescents
    Prakash Bhuyan, MD, PhD ; Joseph Eiden, MD, PhD ; Thomas R. Jones, PhD ; Laura J. York, PhD ; John Ginis ; Kathrin U. Jansen, PhD ; John L. Perez, MD
  • MNB14185.3008.pdf (1.1 MB)
  • Safety, Tolerability, and Immunogenicity of an Investigational Meningococcal Serogroup B Bivalent rLP2086 Vaccine in Healthy Adolescents Aged 11 to 18 Years in Three Phase 2, Randomized, Controlled Studies
    Timo Vesikari, MD, PhD ; Johannes Beeslaar, MD ; Joseph Eiden, MD, PhD ; Qin Jiang, PhD ; Shannon Harris, PhD ; Laura J. York, PhD ; Diana Morgenstern, MD ; Prakash Bhuyan, MD, PhD ; John L. Perez, MD
  • MNB14185.3009.pdf (1.4 MB)
  • Comparative Evaluation of Two Different Investigational Meningococcal ABCWY Vaccine Formulations in Adolescents and Young Adults
    Stan L. Block, MD ; Leszek Szenborn, MD ; Wendy Daly, MD ; Teresa Jackowska, MD ; Vas Narasimhan, MD ; Diego D'Agostino, M.Sc ; Linda Han, MD ; Peter M Dull, MD ; Igor Smolenov, MD
  • 1083_IDPOSTER_SBLOCK.pdf (788.9 kB)
  • Persistence of Meningococcal Antibodies and Response to a Booster Dose after a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents
    Xavier Saez-Llorens, MD ; Diana Catalina Aguilera Vaca, MD ; Katia Abarca, MD ; Emmanuelle Maho, M.Sc ; Linda Han, MD ; Igor Smolenov, MD ; Peter Dull, MD
  • 1084_IDPOSTER_XLlorenz.pdf (962.2 kB)
  • Persistence of Meningococcal Bactericidal Antibodies and Booster Response at 60-Months of Age in Children Who Received Infant Or Toddler Doses of MenACWY-CRM Conjugate Vaccine
    Nicola P. Klein, MD, PhD ; Stan L. Block, MD ; William Johnston, MD ; Sandra Percell, PhD ; Linda Han, MD ; Peter M Dull, MD ; Igor Smolenov, MD
  • Klein_et_al_IDWPoster.pdf (201.8 kB)
  • 5-year Antibody Persistence and Booster Response to a Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults
    Roger Baxter, MD ; Yaela Baine, PhD ; Devayani Kolhe, MSc ; Carmen Baccarini, MD ; Jacqueline M Miller, MD, FAAP ; Marie Van Der Wielen, MD

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, All Rights Reserved.

    Follow IDWeek